Full name
KOMAK-MED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
46.46.Z - Wholesale of pharmaceutical goods
46.19.Z - Agents involved in the sale of a variety of goods
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
72.19.Z - Other research and experimental development on natural sciences and engineering
86.10.Z - Hospital activities
86.22.Z - Specialist medical practice activities
86.90.D - Paramedical activities
86.90.E - Other human health activities notelsewhere classified
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Profit (loss) on sale | 0,1 | 0,4 | 161,6 |
Gross profit (loss) | 0,2 | 0,9 | 277,7 |
EBITDA | 0,4 | 0,9 | 145 |
Short time liabilities | 1,2 | 1 | -19,4 |
Other operating costs | 0,1 | 0 | -46,3 |
Equity capital | 3,1 | 3,9 | 27,3 |
Operating profit (EBIT) | 0,3 | 0,8 | 157,8 |
Assets | 4,3 | 4,9 | 13,7 |
Net profit (loss) | 0,2 | 0,8 | 330,5 |
Cash | 0,4 | 0,9 | 95,9 |
Net income from sale | 3,7 | 3,9 | 5,9 |
Liabilities and provisions for liabilities | 1,3 | 1 | -19,7 |
Working assets | 3,4 | 4 | 16 |
Other income costs | 0,3 | 0,5 | 100,4 |
Depreciation | 0 | 0 | -1 |
% | % | p.p. | |
Profitability of capital | 6,3 | 21,3 | 15 |
Equity capital to total assets | 71,1 | 79,6 | 8,5 |
Gross profit margin | 6,3 | 22,3 | 16 |
EBITDA Margin | 9,6 | 22,2 | 12,6 |
Days | Days | Days | |
Short term commitment turnover cycle | 124 | 95 | -29 |
Current financial liquidity indicator | 2.7355451583862305 | 3.934863328933716 | 1,2 |
Net dept to EBITDA | -0.4719858169555664 | -0.9911792278289795 | -0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane